Oxford BioDynamics (LON:OBD) Share Price Crosses Below 50 Day Moving Average – Should You Sell?

Oxford BioDynamics Plc (LON:OBD)’s share price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 0.27 and traded as low as GBX 0.25. Oxford BioDynamics shares last traded at GBX 0.25, with a volume of 2,200,347 shares changing hands.

Oxford BioDynamics Trading Up 4.0%

The firm has a market capitalization of £11.16 million, a P/E ratio of -0.33 and a beta of 0.42. The business’s 50 day moving average is GBX 0.27 and its two-hundred day moving average is GBX 0.34. The company has a quick ratio of 2.80, a current ratio of 0.88 and a debt-to-equity ratio of 457.97.

Oxford BioDynamics (LON:OBD) last announced its earnings results on Wednesday, December 24th. The biotechnology company reported GBX (0.80) earnings per share (EPS) for the quarter. Oxford BioDynamics had a negative net margin of 1,018.54% and a negative return on equity of 316.67%.

About Oxford BioDynamics

Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.

Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.

In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.